Plain-English translation of NCT07720232 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Phase
Post-approval monitoring
Sponsor
Jianyin Zhou
Enrollment target
~180 participants
Started
January 2026
Primary completion
January 2028
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xu Hongzhi PhD
Jianyin Zhou
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.